After months of threats, President Trump eased up pressure on drugmakers late last year. That’s all it took for investors to notice that the beaten-down sector was actually growing just fine. Talk of ...

Pharma's end-of-year dealmaking flurry is not showing signs of slowing, as, now, two Japanese drugmakers have joined the action with a multibillion-dollar asset transfer agreement. Monday, Shionogi ...

Looking back on 2025, a lot happened in the world of healthcare. This year was largely defined by the arrival of the second Trump administration, armed with tariff threats, unorthodox views about ...

Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation's drug ...

The U.S. is the biggest single market for most pharma and biotech firms. Among the 10 largest biopharmaceutical companies in the Stoxx 600 health index, five get a majority of their total sales from ...

The Council and the European Parliament have reached an agreement on the ‘pharma package’, a new set of rules that will increase patients' access to medicine and make the EU’s pharmaceutical sector ...

For pharmaceutical firms, watching the lucrative patents on their top-selling drugs expire has long been part of the business cycle. There’s enormous pressure to find ways of covering the shortfall.

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Uncertainty reigned early this year with the inauguration of President Donald Trump and his threats to impose tariffs and slash prescription drug prices. But as players in the biopharma industry have ...

Mitsubishi Tanabe Pharma has undergone a rebrand. Following a ¥510 billion ($3.3 billion) takeover by Bain Capital, the 350-year-old company has dropped the Mitsubishi from its name and those of its ...

For two decades, the branded pharma website has been treated as the centerpiece of digital engagement. It has been the polished ‘front door’, where brands prepared to tell their story and hoped ...